Turnover
| Year | Value | Change vs previous year |
|---|---|---|
| 2022 | 0 zł | |
| 2023 | 14,498 zł | |
| 2024 | 5,400 zł |
Key financial results based on available financial statements for 2022–2024.
Turnover
2023: 14,498 zł
Profit before tax
2023: 2,387 zł
Net Profit
2023: 1,971 zł
Equity
2023: 38,894 zł
In 2024, BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ reported turnover of 5,400 zł. Other key financial indicators include profit before tax of 2,345 zł, net profit of 2,134 zł, and equity of 41,028 zł. Current liabilities fell from 68,304 zł in 2023 to 58,435 zł in 2024 (-14%). Detailed financial data for 2022–2024 is available in the table below. View financial data by year.
Select a financial indicator to view its historical performance and annual changes.
Turnover
Annual change
Turnover as filed for 2022–2024. Every figure in this chart is also in the financial history table.
See how the company’s financial results changed over the reported years 2022–2024. Compare annual figures and identify the biggest increases and decreases.
| Year | Value | Change vs previous year |
|---|---|---|
| 2022 | 0 zł | |
| 2023 | 14,498 zł | |
| 2024 | 5,400 zł |
| Year | Value | Change vs previous year |
|---|---|---|
| 2022 | -3,077 zł | |
| 2023 | 2,387 zł | |
| 2024 | 2,345 zł |
| Year | Value | Change vs previous year |
|---|---|---|
| 2022 | -3,077 zł | |
| 2023 | 1,971 zł | |
| 2024 | 2,134 zł |
| Year | Value | Change vs previous year |
|---|---|---|
| 2022 | 36,924 zł | |
| 2023 | 38,894 zł | |
| 2024 | 41,028 zł |
+5.4% a year (CAGR)
Explore key financial ratios to better understand the company’s financial position and performance.
Explore the company’s financial data over the years and compare historical results.
Financial data for BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ, based on available financial statements. A dash (–) indicates that data for the selected year is unavailable.
| Indicator | 2022 | 2023 | 2024 |
|---|---|---|---|
| Turnoverzł | 0 | 14,498 | 5,400 |
| Profit before taxzł | -3,077 | 2,387 | 2,345 |
| Net Profitzł | -3,077 | 1,971 | 2,134 |
| Equityzł | 36,924 | 38,894 | 41,028 |
| Current liabilitieszł | 22,678 | 68,304 | 58,435 |
| Non current liabilitieszł | 0 | – | – |
| Non-current Assetszł | 0 | – | – |
Answers based on BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ’s available financial data.
Yes. Okredo holds filed figures for BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ covering 2022–2024, across 7 reported indicators. The most recent reported year is 2024.
BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ reported turnover of 5,400 zł for 2024. That compares with 14,498 zł in 2023, a change of -63%.
BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ reported profit before tax of 2,345 zł for 2024. That compares with 2,387 zł in 2023, a change of -2%.
BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ reported net profit of 2,134 zł for 2024. That compares with 1,971 zł in 2023, a change of 8%.
Explore how 4 financial indicators changed for BUDPHARMA GROUP SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ between 2022 and 2024. The largest increase was in Equity, at +11.1%. The compound annual growth rate of Equity was +5.4% over the period.
Financial data is available for 2022, 2023, and 2024. A dash (–) in the financial history table indicates unavailable data.